Navigation Links
Ethicon Endo-Surgery Announces Agreement with Hologic Inc. To Resolve Patent Disputes
Date:2/19/2010

CINCINNATI, Feb. 19 /PRNewswire/ -- Ethicon Endo-Surgery, Inc., a Johnson & Johnson company, announced today that it has reached an agreement with Hologic, Inc., and Hologic subsidiary Suros Surgical Systems, Inc., settling litigation in Ohio and dismissing pending cases in Delaware.  The disputes involved patents relating to the Ethicon Endo-Surgery MAMMOTOME® Breast Biopsy System, and the Hologic ATEC and EVIVA biopsy devices. Under the terms of the agreement, Ethicon Endo-Surgery will receive $12.5 million from Hologic.

As part of the settlement, Ethicon Endo-Surgery and Hologic will enter into a cross licensing agreement, whereby Hologic will pay ongoing royalties on the sales of ATEC and EVIVA hand pieces, and Ethicon Endo-Surgery will pay ongoing royalties on the sales of the MAMMOTOME® MR, effective February 19, 2010.

The cases resolved were in trial in Ohio before U.S. District Court Judge Barrett, and pending trial in Delaware before U.S. District Court Judge Farnan.


"We are pleased to resolve this longstanding litigation with Hologic," said Kevin Lobo, Worldwide President, Ethicon Endo-Surgery. "We firmly stand behind our intellectual property, which allows us to bring innovative products to market and advance patient care."

About Ethicon Endo-Surgery, Inc.

Ethicon Endo-Surgery, Inc. is a global leader in minimally invasive and traditional surgical devices for bariatric surgery and many other areas of surgery. The company develops and markets advanced medical devices for minimally invasive and open surgical procedures. The company focuses on procedure-enabling devices for the interventional diagnosis and treatment of conditions in general and bariatric surgery, as well as gastrointestinal health, plastic surgery, orthopedics, gynecology and surgical oncology. More information on the company can be found at www.ethiconendo.com.

(This press release contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could vary materially from Ethicon Endo-Surgery, Inc. and/or Johnson & Johnson's expectations and projections. Risks and uncertainties include general industry conditions and competition; economic conditions, such as interest rate and currency exchange rate fluctuations; technological advances and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approvals; domestic and foreign health care reforms and governmental laws and regulations; and trends toward health care cost containment.  A further list and description of these risks, uncertainties and other factors can be found in Exhibit 99 of the Johnson & Johnson Annual Report on Form 10-K for the fiscal year ended December 28, 2008. Copies of this Form 10-K, as well as subsequent filings, are available online at www.sec.gov, www.jnj.com or on request from Johnson & Johnson. Neither Ethicon Endo-Surgery, Inc. nor Johnson & Johnson undertake to update any forward-looking statements as a result of new information or future events or developments.)

SOURCE Ethicon Endo-Surgery, Inc.

Back to top

RELATED LINKS
www.ethiconendo.com

'/>"/>

SOURCE Ethicon Endo-Surgery, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Ethicon Completes Acquisition of Acclarent
2. Ethicon Announces Definitive Agreement to Acquire Acclarent
3. Ethicon Endo-Surgery Introduces Innovation-Enabling Solutions Across the Spectrum of Surgery at ACS
4. Ethicon Endo-Surgery Unveils Full Energy Portfolio for First Time at American College of Surgeons Clinical Congress
5. Ethicon Endo-Surgery Launches New Echelon Flex(TM) Endopath(R) Stapler That Delivers Echelon(TM) Compression, Now With Natural Articulation
6. Ethicon Endo-Surgery Wins Prestigious International Design Award for Innovative Development of HARMONIC FOCUS(TM)
7. First Patient of NOTES Investigational Device Exemption (IDE) Study Successfully Treated With Ethicon Endo-Surgery Devices
8. Ethicon Endo-Surgery Studies Presented at DDW Demonstrate Potential of Pure NOTES Surgery With Companys Toolbox
9. Pioneer(R) Surgical Technology, Inc. Announces New CTO
10. Jazz Pharmaceuticals Announces FDA Acceptance of its New Drug Application for JZP-6 (sodium oxybate) for the Treatment of Fibromyalgia
11. Echo Therapeutics Announces Significant Product Development Milestone: The Completion of Next Generation Electronic Components for Its Revolutionary, Patented Symphony(TM) tCGM System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... India , April 29, 2016 ... Pipeline Review, H1 2016" market research report that ... complete with comparative analysis at various stages, therapeutics ... route of administration (RoA) and molecule type, along ... releases. It also reviews key players involved in ...
(Date:4/29/2016)... , April 29, 2016 /PRNewswire/ ... Contamine, Directeur Financier Sanofi, ... santé, publie ses résultats pour le ... du Groupe, Jérôme Contamine, commente les ... et les perspectives pour le reste ...
(Date:4/29/2016)... India , April 29, 2016 ... the life science laboratory due to the growing demands ... by advance technology, contemporary automated systems are already adept ... performed by slow, tedious and manual labor. Instrumentation continues ... were not even conceivable just a few years ago. ...
Breaking Medicine Technology:
(Date:5/4/2016)... ... May 04, 2016 , ... Mediware Information ... therapy software application that helps blood and marrow transplant (BMT) programs meet compliance ... launch, Mediware has continued to enhance core application features. These enhancements are designed ...
(Date:5/4/2016)... ... May 04, 2016 , ... International Conference on Obesity and ... 2016 at Las Vegas. It aims to bring together academicians, scientists, dietitians, surgeons, ... organizations across the globe; making the conference a perfect platform to share experience ...
(Date:5/3/2016)... (PRWEB) , ... May 04, 2016 , ... The ... 2016-2017 inductee into its VIP Woman of the Year Circle. She is recognized with ... exclusively for professional women, boasting more than 850,000 members and over 200 operating Local ...
(Date:5/3/2016)... , ... May 03, 2016 , ... Sue Desmond-Hellmann, chief ... of 2016 to stretch the limits of human possibility in her keynote address at ... in the Georgia Dome. , Drawing on her rich experience as a scientist, physician ...
(Date:5/3/2016)... ... May 03, 2016 , ... With the opioid epidemic now ... excessive levels of alcohol use. Alcohol and its misuse causes long-term consequences for ... the susceptibility to strokes in those 65 years and older. In addition, there ...
Breaking Medicine News(10 mins):